| dc.contributor.author | EŞKAZAN, AHMET EMRE | |
| dc.contributor.author | GÜLTÜRK, Emine | |
| dc.contributor.author | SALİHOĞLU, Ayşe | |
| dc.contributor.author | EKİZOĞLU ERATAK, Seda | |
| dc.contributor.author | TANRIKULU ŞİMŞEK, Eda | |
| dc.contributor.author | ÖNGÖREN, Şeniz | |
| dc.contributor.author | DEMİRÖZ, AHU SENEM | |
| dc.contributor.author | CENGİZ, Mahir | |
| dc.contributor.author | AR, CEM | |
| dc.contributor.author | ELVERDİ, TUĞRUL | |
| dc.contributor.author | FERHANOĞLU, BURHAN | |
| dc.contributor.author | TÜZÜNER TUNÇAY, Nuriye Nukhet | |
| dc.contributor.author | AYDIN, Yıldız | |
| dc.contributor.author | SOYSAL, Teoman | |
| dc.contributor.author | BUYRU, Ayşe Nur | |
| dc.contributor.author | ÖZBEK, Uğur | |
| dc.contributor.author | BAŞLAR, Zafer | |
| dc.date.accessioned | 2021-03-05T14:08:31Z | |
| dc.date.available | 2021-03-05T14:08:31Z | |
| dc.identifier.citation | TANRIKULU ŞİMŞEK E., EŞKAZAN A. E. , CENGİZ M., AR C., EKİZOĞLU ERATAK S., SALİHOĞLU A., GÜLTÜRK E., ELVERDİ T., ÖNGÖREN Ş., DEMİRÖZ A. S. , et al., ". Imatinib Mesylate Reduces Bone Marrow Fibrosis and Overwhelms the Adverse Prognostic Impact of Reticulin Formation in Patients with Chronic Myeloid Leukemi", 57th ASH Annual Meeting and Exposition, Orlando, Amerika Birleşik Devletleri, 5 - 08 Aralık 2015 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_b5ae9267-b6f6-4cb9-b09b-5d2fcfe84c6b | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/120928 | |
| dc.language.iso | eng | |
| dc.subject | Moleküler Biyoloji ve Genetik | |
| dc.subject | Yaşam Bilimleri | |
| dc.subject | Moleküler Biyoloji ve Genetik | |
| dc.subject | Temel Bilimler | |
| dc.subject | Yaşam Bilimleri (LIFE) | |
| dc.title | . Imatinib Mesylate Reduces Bone Marrow Fibrosis and Overwhelms the Adverse Prognostic Impact of Reticulin Formation in Patients with Chronic Myeloid Leukemi | |
| dc.type | Bildiri | |
| dc.contributor.department | Diğer Kurumlar , , | |
| dc.contributor.firstauthorID | 399785 | |
